{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:09:08Z","timestamp":1784578148077,"version":"3.55.0"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:00:00Z","timestamp":1339545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038911","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T21:02:46Z","timestamp":1339621366000},"page":"e38911","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lack of Evidence for Neonatal Misoprostol Neurodevelopmental Toxicity in C57BL6\/J Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Claire M.","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl K.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac N.","family":"Pessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0033291799008508","article-title":"The epidemiology of autism: a review.","volume":"29","author":"E Fombonne","year":"1999","journal-title":"Psychol Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.285.24.3093","article-title":"Pervasive developmental disorders in preschool children.","volume":"285","author":"S Chakrabarti","year":"2001","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.108.5.1155","article-title":"Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.","volume":"108","author":"J Bertrand","year":"2001","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/EDE.0b013e3181902d15","article-title":"The rise in autism and the role of age at diagnosis.","volume":"20","author":"I Hertz-Picciotto","year":"2009","journal-title":"Epidemiology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1542\/peds.2010-1036","article-title":"Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis.","volume":"128","author":"H Gardener","year":"2011","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.dhjo.2009.10.008","article-title":"Changes in autism spectrum disorder prevalence in 4 areas of the United States.","volume":"3","author":"C Rice","year":"2010","journal-title":"Disabil Health J"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism.","author":"J Hallmayer","year":"2011"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.neuro.2008.02.006","article-title":"Immunologic and neurodevelopmental susceptibilities of autism.","volume":"29","author":"IN Pessah","year":"2008","journal-title":"Neurotoxicology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mrdd.20043","article-title":"Identifying environmental contributions to autism: provocative clues and false leads.","volume":"10","author":"CP Lawler","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MOP.0b013e328336eb9a","article-title":"What causes autism? Exploring the environmental contribution.","volume":"22","author":"PJ Landrigan","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1289\/ehp.1002835","article-title":"Residential proximity to freeways and autism in the CHARGE study.","volume":"119","author":"HE Volk","year":"2011","journal-title":"Environ Health Perspect"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"A155","DOI":"10.1289\/ehp.11010","article-title":"The interaction of agricultural pesticides and marginal iodine nutrition status as a cause of autism spectrum disorders.","volume":"116","author":"KM Sullivan","year":"2008","journal-title":"Environ Health Perspect"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"A504","DOI":"10.1289\/ehp.115-a504a","article-title":"Autism and agricultural pesticides. Integrating data to track trends.","volume":"115","author":"V McGovern","year":"2007","journal-title":"Environ Health Perspect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/EDE.0b013e31821d0e30","article-title":"Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism.","volume":"22","author":"RJ Schmidt","year":"2011","journal-title":"Epidemiology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mehy.2011.03.013","article-title":"Is excess folic acid supplementation a risk factor for autism?","volume":"77","author":"CM Beard","year":"2011","journal-title":"Med Hypotheses"},{"key":"ref16","article-title":"Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies.","author":"CM Hultman","year":"2010"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2009.187708","article-title":"Advancing paternal and maternal age are both important for autism risk.","author":"A Reichenberg","year":"2010"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archpedi.161.4.334","article-title":"Maternal and paternal age and risk of autism spectrum disorders.","volume":"161","author":"LA Croen","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/WNL.0b013e3181af0b95","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs.","volume":"73","author":"ML Evatt","year":"2009","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/11207230-000000000-00000","article-title":"Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.","volume":"13","author":"MP Curran","year":"2011","journal-title":"Paediatr Drugs"},{"key":"ref21","first-page":"35","article-title":"Autism and vaccines: search for cause amidst controversy.","volume":"52","author":"J Bell","year":"2011","journal-title":"J Miss State Med Assoc"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/S0004-282X2003000200004","article-title":"Autism and Mobius sequence: an exploratory study of children in northeastern Brazil.","volume":"61","author":"JM Bandim","year":"2003","journal-title":"Arq Neuropsiquiatr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/bdra.20609","article-title":"Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected.","volume":"85","author":"MT Miller","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref24","first-page":"315","article-title":"Is misoprostol teratogenic? Misoprostol use during early pregnancy and its association with Mobius' syndrome.","volume":"45","author":"K Pottie","year":"1999","journal-title":"Can Fam Physician"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A male with fetal valproate syndrome and autism.","volume":"39","author":"PG Williams","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association.","volume":"43","author":"G Williams","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.05.026","article-title":"Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?","author":"FR Witter","year":"2011"},{"key":"ref28","first-page":"131","article-title":"Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat.","author":"HO Borbe","year":"1990"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1023\/A:1018895417831","article-title":"Improving the gastrointestinal safety of NSAIDs: the development of misoprostol\u2013from hypothesis to clinical practice.","volume":"43","author":"FE Silverstein","year":"1998","journal-title":"Dig Dis Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7326\/ACPJC-2005-142-3-075","article-title":"Review: misoprostol or COX-2-specific or selective NSAIDs reduce gastrointestinal complications and symptomatic ulcers.","volume":"142","author":"VW Wong","year":"2005","journal-title":"ACP J Club"},{"key":"ref31","first-page":"31","article-title":"Misoprostol: new frontiers; benefits beyond the gastrointestinal tract.","author":"MJ Shield","year":"1992"},{"key":"ref32","first-page":"22","article-title":"Misoprostol (Cytotec): a new method of inducing labor.","author":"J Enoch","year":"1999"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9378(99)70558-2","article-title":"Labor induction with misoprostol.","volume":"181","author":"DA Wing","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/ejpn.2001.0540","article-title":"Mobius sequence\u2013a Swedish multidiscipline study.","volume":"6","author":"K Stromland","year":"2002","journal-title":"European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0447.1999.tb00984.x","article-title":"Autism: not an extremely rare disorder.","volume":"99","author":"C Gillberg","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neubiorev.2010.12.013","article-title":"Fetal exposure to teratogens: evidence of genes involved in autism.","volume":"35","author":"D Dufour-Rainfray","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajhg.2007.12.009","article-title":"Structural variation of chromosomes in autism spectrum disorder.","volume":"82","author":"CR Marshall","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng1985","article-title":"Mapping autism risk loci using genetic linkage and chromosomal rearrangements.","volume":"39","author":"P Szatmari","year":"2007","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2010.06.098","article-title":"Prostaglandin E(2) and misoprostol induce neurite retraction in Neuro-2a cells.","volume":"398","author":"J Tamiji","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","first-page":"565","article-title":"Misoprostol elevates intracellular calcium in Neuro-2a cells via protein kinase A. Biochem Biophys Res Commun","volume":"399","author":"J Tamiji","year":"2010"},{"key":"ref41","first-page":"251","article-title":"The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3.","volume":"76","author":"DR Haynes","year":"1992","journal-title":"Immunology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1128\/MCB.14.7.4443","article-title":"Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.","volume":"14","author":"U Dendorfer","year":"1994","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00045391-199512000-00002","article-title":"Preliminary Studies of in vitro and in vivo Effects of Misoprostol on Th-1 and Th-2 Cytokine Production.","volume":"2","author":"V Rus","year":"1995","journal-title":"Am J Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00045391-199510000-00007","article-title":"Suppression of IL-4 Production in Murine Lymphocytes by Orally Effective Prostaglandin E(1) Analogs.","volume":"2","author":"CW Parker","year":"1995","journal-title":"Am J Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/00221300209602104","article-title":"Behavioral and motivational effects of immune-system activation.","volume":"129","author":"SJ Larson","year":"2002","journal-title":"J Gen Psychol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-3233(08)60437-4","article-title":"Cytokines in brain development and function.","volume":"52","author":"MF Mehler","year":"1998","journal-title":"Adv Protein Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ni1078","article-title":"Elaborate interactions between the immune and nervous systems.","volume":"5","author":"L Steinman","year":"2004","journal-title":"Nat Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/10446670410001722096","article-title":"A review of autism and the immune response.","volume":"11","author":"P Ashwood","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research.","volume":"80","author":"P Ashwood","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e20470","DOI":"10.1371\/journal.pone.0020470","article-title":"Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.","volume":"6","author":"K Suzuki","year":"2011","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.","volume":"25","author":"P Ashwood","year":"2011","journal-title":"Brain Behav Immun"},{"key":"ref52","article-title":"Walker CK KP, Hansen RL, Hertz-Picciotto I. (May, 2008) Induction and augmentation of labor and autism."},{"key":"ref53","first-page":"695","article-title":"Determining dose and endpoints of a controlled-release misoprostol vaginal insert for a phase III trial.","volume":"53","author":"DA Wing","year":"2008","journal-title":"J Reprod Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajog.2005.05.087","article-title":"High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.","volume":"193","author":"FS Nuthalapaty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.00108s3511","article-title":"Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.","volume":"108","author":"D Rice","year":"2000","journal-title":"Environ Health Perspect"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","article-title":"Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains.","volume":"176","author":"SS Moy","year":"2007","journal-title":"Behavioural brain research"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/hbeh.1997.1382","article-title":"A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice.","volume":"31","author":"JN Crawley","year":"1997","journal-title":"Horm Behav"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.08.001.2007","article-title":"Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf\/J, C57BL\/6J, and vasopressin receptor 1B mutant mice.","volume":"1","author":"M Yang","year":"2007","journal-title":"Frontiers in behavioral neuroscience"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneumeth.2011.02.005","article-title":"The effect of intraperitoneally administered dimethyl sulfoxide on absence-like epileptic activity of freely moving WAG\/Rij rats.","volume":"197","author":"Z Kovacs","year":"2011","journal-title":"Journal of neuroscience methods"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/RNN-2008-00441","article-title":"Dimethyl sulfoxide provides neuroprotection in a traumatic brain injury model.","volume":"26","author":"AM Di Giorgio","year":"2008","journal-title":"Restorative neurology and neuroscience"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(74)90863-4","article-title":"A developmental time scale for postnatal changes in brain and behavior of B6D2F2 mice.","volume":"72","author":"D Wahlsten","year":"1974","journal-title":"Brain Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice.","volume":"3","author":"SS Moy","year":"2004","journal-title":"Genes Brain Behav"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1601-183X.2006.00240.x","article-title":"Complex, multimodal behavioral profile of the Homer1 knockout mouse.","volume":"6","author":"PJ Jaubert","year":"2007","journal-title":"Genes Brain Behav"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(00)00449-4","article-title":"Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal.","volume":"68","author":"EE Irvine","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse.","volume":"92","author":"RG Lister","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/S0028-3908(00)00030-7","article-title":"Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice.","volume":"39","author":"SC Dulawa","year":"2000","journal-title":"Neuropharmacology"},{"key":"ref67","first-page":"238","article-title":"Presidential Address, 1974. The more or less startling effects of weak prestimulation.","volume":"12","author":"FK Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0300-483X(88)90185-0","article-title":"The hippocampus as a common target of neurotoxic agents.","volume":"49","author":"TJ Walsh","year":"1988","journal-title":"Toxicology"},{"key":"ref69","article-title":"The Mouse Brain in Sterotaxic Coordinates, 2nd Edition.","author":"G Paxinos","year":"2001"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainresbull.2008.06.006","article-title":"Prostaglandin analogue misoprostol attenuates neurotoxin 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells.","volume":"77","author":"EJ Choi","year":"2008","journal-title":"Brain research bulletin"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2008.04.054","article-title":"Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.","volume":"438","author":"J Li","year":"2008","journal-title":"Neuroscience letters"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/BF02093790","article-title":"Misoprostol protection against acetaminophen-induced hepatotoxicity in the rat.","volume":"39","author":"SP Lim","year":"1994","journal-title":"Digestive diseases and sciences"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2307\/3578740","article-title":"Misoprostol-induced radioprotection of Syrian hamster embryo cells in utero from cell death and oncogenic transformation.","volume":"139","author":"RC Miller","year":"1994","journal-title":"Radiation research"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1073858406296401","article-title":"The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?","volume":"13","author":"U Meyer","year":"2007","journal-title":"Neuroscientist"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1615\/CritRevNeurobiol.v17.i1.20","article-title":"On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies.","volume":"17","author":"KT LePage","year":"2005","journal-title":"Critical reviews in neurobiology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2011.09.005","article-title":"Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.","volume":"504","author":"H Taniguchi","year":"2011","journal-title":"Neuroscience letters"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1017\/S0012162201000627","article-title":"Autistic spectrum disorders in Mobius sequence: a comprehensive study of 25 individuals.","volume":"43","author":"M Johansson","year":"2001","journal-title":"Dev Med Child Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:00:27Z","timestamp":1743408027000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038911"}},"subtitle":[],"editor":[{"given":"Olivier","family":"Baud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":77,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038911","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]}}}